Back to today’s briefing

Story perspectives

North Carolina's Mifepristone Access at Risk Amid Federal Review

3/1/2025

25 6

Left

Kennedy Challenges Mifepristone

North Carolina's access to mifepristone hangs in the balance as newly appointed Health Secretary Robert F. Kennedy Jr. calls for a federal review of the drug's approval. Advocates fear that limiting this vital medication, essential for abortions and miscarriages, could jeopardize women's health and further undermine reproductive rights in the state.

Center

San Antonio Supports Abortion

In a bold move, the San Antonio City Council's Community Health Committee greenlit a $100,000 plan to support abortion travel services, defying state restrictions. This decision comes on the heels of a $500,000 reproductive health fund that overlooked travel needs. Meanwhile, Connecticut is set to allocate $800,000 to secure mifepristone, safeguarding access amid federal challenges.

History

Historical Context

North Carolina's current debate over mifepristone echoes historical struggles over reproductive rights in the U.S. The FDA's accelerated drug approval process, initiated in 1992, aimed to expedite access to essential medications. This mirrors past controversies, like the AIDS activism of the 1980s, where advocates fought for quicker access to life-saving treatments, highlighting ongoing tensions between health policy and individual rights.

1 of 3

Kennedy Challenges Mifepristone

North Carolina's access to mifepristone hangs in the balance as newly appointed Health Secretary Robert F. Kennedy Jr. calls for a federal review of the drug's approval. Advocates fear that limiting this vital medication, essential for abortions and miscarriages, could jeopardize women's health and further undermine reproductive rights in the state.

1 / 3